• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    1/18/23 1:25:40 PM ET
    $ACHR
    $AGRI
    $ANY
    $ARVL
    Aerospace
    Industrials
    Metal Fabrications
    Industrials
    Get the next $ACHR alert in real time by email

    Gainers

    • Ontrak, Inc. (NASDAQ:OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ program members.
    • Aceragen Inc. (NASDAQ:ACGN) shares gained 61.3% to $11.65.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) gained 44% to $7.07 after the company on Tuesday announced a strategic collaboration to advance gamma-delta T cells in oncology.
    • Energy Vault Holdings, Inc. (NYSE:NRGV) shares gained 42.4% to $5.08 after the company updated Q4 and FY22 expected revenue results.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) jumped 34.6% to $4.66.
    • Sigilon Therapeutics, Inc. (NASDAQ:SGTX) climbed 32.8% to $0.5488 after Canaccord Genuity initiated coverage on the stock with a Buy rating and a $6 price target.
    • Digihost Technology Inc. (NASDAQ:DGHI) rose 32.2% to $1.39.
    • Atlas Lithium Corporation (NASDAQ:ATLX) gained 28.5% to $10.93 after the company announced it signed a MOU with Mitsui & Co. with respect to Mitsui's potential interest in acquiring the right to purchase Atlas Lithium's future lithium concentrate production.
    • Magic Empire Global Limited (NASDAQ:MEGL) climbed 27% to $2.6650.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) rose 25.4% to $0.5940 after the company announced strategic agreement with the City of Huanggang and signed a new shareholder agreement with FF Global Partners.
    • Tricida, Inc. (NASDAQ:TCDA) gained 23.1% to $0.1632.
    • AMTD Digital Inc. (NYSE:HKD) surged 22.2% to $13.10.
    • Nuvve Holding Corp. (NASDAQ:NVVE) jumped 19.8% to $1.45.
    • Siyata Mobile Inc. (NASDAQ:SYTA) rose 19.8% to $0.2756 after the company announced it received follow-on orders for its UV350 device from a leading Saudi Arabian cellular carrier.
    • Archer Aviation Inc. (NYSE:ACHR) gained 19.2% to $3.0750 following Form 4 filings which showed insider buys from director and CEO Adam D Goldstein and director Fred M Diaz.
    • RenovoRx, Inc. (NASDAQ:RNXT) jumped 19% to $4.70 after the company announced initial results from a pharmacokinetic substudy within the Phase 3 TIGeR-PaC clinical trial to be presented at the 2023 ASCO Gastrointestinal Cancers Symposium between January 19-21.
    • GSE Systems, Inc. (NASDAQ:GVP) gained 18.1% to $0.85. GSE announced renewed 5-year contract with additional options worth up to $28.3 million for engineering services.
    • Volta Inc. (NYSE:VLTA) jumped 18.1% to $0.8588 after the company announced it will be acquires by Shell USA.
    • VBI Vaccines Inc. (NASDAQ:VBIV) climbed 15.8% to $0.6969.
    • Evolus, Inc. (NASDAQ:EOLS) gained 15.6% to $9.78 after the company announced preliminary unaudited Q4 and FY22 net revenue.
    • PureTech Health plc (NASDAQ:PRTC) gained 13% to $33.37.
    • Celyad Oncology SA (NASDAQ:CYAD) shares rose 12% to $2.13 after jumping 138% on Tuesday. Celyad Oncology recently issued an update on its Celyad 2.0 business strategy, which has been adopted and implemented over the last few months.
    • AVITA Medical, Inc. (NASDAQ:RCEL) rose 11.4% to $8.98 after gaining around 7% on Tuesday. AVITA Medical, last month, submitted FDA PMA application to expand indication to vitiligo.
    • Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) rose 10.6% to $1.2506. Citius Pharmaceuticals, last month, reported FY22 earnings results.
    • Moderna, Inc. (NASDAQ:MRNA) rose 8.5% to $206.99 after the company's syncytial virus vaccine candidate met its primary endpoint in a Phase 3 trial.
    • Carvana Co. (NYSE:CVNA) gained 7% to $7.82. Carvana adopted a shareholder rights plan to protect long-term shareholder value by preserving the availability of net operating loss carryforwards (NOLs) and other tax attributes under the Internal Revenue Code.


    Losers

    • Bit Brother Limited (NASDAQ:BTB) shares dipped 66.7% to $2.21 after the company reported pricing of $7.1 million registered direct offering.
    • Arcimoto, Inc. (NASDAQ:FUV) fell 59.8% to $2.21 after the company announced pricing of its $12 million public offering.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) dropped 24% to $0.45.
    • Universe Pharmaceuticals INC (NASDAQ:UPC) shares declined 23.6% to $0.8859.
    • Greenidge Generation Holdings Inc. (NASDAQ:GREE) fell 22.6% to $0.7580.
    • Calyxt, Inc. (NASDAQ:CLXT) dropped 20.6% to $0.2805.
    • Arrival (NASDAQ:ARVL) fell 20.5% to $0.4850.
    • Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) dropped 20.3% to $5.56.
    • AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) dipped 19.7% to $1.2850. AgriFORCE and the Government of Barbados signed a MOU to collaborate on the market evaluation and development of controlled environment facilities in barbados to address nutrition and food security in the Caribbean.
    • TeraWulf Inc. (NASDAQ:WULF) dropped 19.6% to $0.8198.
    • MGO Global Inc. (NASDAQ:MGOL) fell 19.2% to $3.9562.
    • PAVmed Inc. (NASDAQ:PAVM) dipped 18% to $0.5211 after the company announced a workforce reduction of roughly 20% alongside other cost-cutting measures.
    • SOS Limited (NYSE:SOS) dropped 17.1% to $6.79.
    • Sphere 3D Corp. (NASDAQ:ANY) fell 17% to $0.38.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) dipped 16.4% to $7.01.
    • Hut 8 Mining Corp. (NASDAQ:HUT) dropped 16.4% to $1.5390.
    • Boxed, Inc. (NYSE:BOXD) fell 16.3% to $0.4909. Boxed recently announced its Spresso Saas modular solution platform is now available on Google Cloud.
    • Bright Health Group, Inc. (NYSE:BHG) dropped 13.4% to $0.9011. Bright Health Group recently announced it increased 2023 Enterprise Revenue guidance to $3.4 - $3.6 billion.
    • Chegg, Inc. (NYSE:CHGG) fell 12.2% to $21.45. Needham downgraded Chegg from Buy to Hold.
    • Riot Platforms, Inc. (NASDAQ:RIOT) dropped 11.4% to $5.68.
    • Calyxt, Inc. (NASDAQ:CLXT) fell 10.8% to $0.3151. Calyxt shares jumped over 90% on Tuesday after the company and Cibus announced a definitive merger agreement.
    • BIT Mining Limited (NYSE:BTCM) shares dropped 6.8% to $4.06. BIT Mining shares jumped 42% on Tuesday after the company announced the launch of a new energy efficient LiteCoin/DogeCoin Miner, LD3.

    Also Check This Out ReWalk Robotics, American Resources And These 2 Penny Stocks Insiders Are Aggressively Buying

    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $AGRI
    $ANY
    $ARVL

    CompanyDatePrice TargetRatingAnalyst
    Carvana Co.
    $CVNA
    4/6/2026$360.00Buy → Neutral
    BofA Securities
    TeraWulf Inc.
    $WULF
    3/23/2026$30.00Buy
    Arete
    Hut 8 Corp.
    $HUT
    3/23/2026$136.00Buy
    Arete
    Avita Medical Inc.
    $RCEL
    3/5/2026$10.00Outperform
    Northland Capital
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    TeraWulf Inc.
    $WULF
    2/9/2026$37.00Overweight
    Morgan Stanley
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    Hut 8 Corp.
    $HUT
    2/2/2026$80.00Buy
    H.C. Wainwright
    More analyst ratings

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Strategy Officer Langlais Kerri M. converted options into 327,054 shares and returned 180,860 shares to the company, increasing direct ownership by 4% to 3,864,493 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    4/24/26 9:35:45 PM ET
    $WULF
    EDP Services
    Technology

    Chief Executive Officer Prager Paul B. converted options into 981,162 shares and returned 542,582 shares to the company, increasing direct ownership by 66% to 1,101,020 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    4/24/26 9:35:19 PM ET
    $WULF
    EDP Services
    Technology

    Chief Financial Officer Fleury Patrick returned 128,695 shares to the company and converted options into 327,054 shares, increasing direct ownership by 6% to 3,608,801 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    4/24/26 9:34:57 PM ET
    $WULF
    EDP Services
    Technology

    $ACHR
    $AGRI
    $ANY
    $ARVL
    SEC Filings

    View All

    Citius Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Citius Pharmaceuticals, Inc. (0001506251) (Filer)

    4/24/26 5:00:16 PM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nuvve Holding Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

    8-K - Nuvve Holding Corp. (0001836875) (Filer)

    4/24/26 4:55:52 PM ET
    $NVVE
    Electrical Products
    Industrials

    SEC Form 424B5 filed by Citius Pharmaceuticals Inc.

    424B5 - Citius Pharmaceuticals, Inc. (0001506251) (Filer)

    4/24/26 9:24:38 AM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $AGRI
    $ANY
    $ARVL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 18, 2022 - FDA Alerts the Public to Potentially Contaminated Products from Family Dollar Stores in Six States

    For Immediate Release: February 18, 2022 Today, the U.S. Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. 1, 2021, through the present from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use. The impacted products originated from the company’s distribution facility in

    2/18/22 8:06:10 PM ET
    $ARVL
    Auto Manufacturing
    Consumer Discretionary

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules

    CRANFORD, N.J., April 24, 2026 /PRNewswire/ -- Citius Pharmaceuticals Inc. (NASDAQ:CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase of an aggregate of 5,076,143 shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $0.985 per share (or pre-funded warrant in lieu thereof). In a concurrent private placement, the Company issued unregistered warrants to purchase up to 5,076,143 shares of common stock at an exe

    4/24/26 4:30:00 PM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Energy Vault Holdings, Inc. Announces New Hire Awards Under NYSE Listing Rule 303A.08

    Energy Vault Holdings, Inc. ("Energy Vault") (NYSE:NRGV), a global energy storage company today announced that, effective on March 11, 2026, the Compensation Committee of Energy Vault's Board of Directors granted to 4 new employees restricted stock unit and performance-based restricted stock unit awards covering an aggregate 353,500 shares of its common stock under the Energy Vault Holdings, Inc. 2022 Employment Inducement Award Plan (as amended and/or restated, the "Plan"). The awards were granted as awards material to new employees entering into employment with Energy Vault in accordance with New York Stock Exchange Listing Rule 303A.08. The restricted stock units vest over four years a

    4/24/26 4:30:00 PM ET
    $NRGV
    Industrial Machinery/Components
    Miscellaneous

    Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

    NEW YORK, April 24, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced the closing of its previously announced underwritten registered direct offering of 18,000,000 common shares at a purchase price of $1.00 per share, anchored by a $15 million investment from a fundamental institutional investor with support from a large existing shareholder. The gross proceeds from the offering, before deducting underwriting discount

    4/24/26 10:23:00 AM ET
    $LUCD
    $PAVM
    Medical/Dental Instruments
    Health Care

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bucella Michael C. bought $19,950 worth of shares (1,338 units at $14.91), increasing direct ownership by 0.49% to 273,552 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/13/26 5:49:13 PM ET
    $WULF
    EDP Services
    Technology

    Director Bucella Michael C. bought $30,071 worth of shares (2,085 units at $14.42), increasing direct ownership by 0.77% to 272,214 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/9/26 7:31:19 PM ET
    $WULF
    EDP Services
    Technology

    Director Ertel Thomas R bought $18,366 worth of shares (5,450 units at $3.37), increasing direct ownership by 2% to 365,788 units (SEC Form 4)

    4 - Energy Vault Holdings, Inc. (0001828536) (Issuer)

    3/5/26 11:53:24 AM ET
    $NRGV
    Industrial Machinery/Components
    Miscellaneous

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Carvana downgraded by BofA Securities with a new price target

    BofA Securities downgraded Carvana from Buy to Neutral and set a new price target of $360.00

    4/6/26 8:41:44 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Arete initiated coverage on TeraWulf with a new price target

    Arete initiated coverage of TeraWulf with a rating of Buy and set a new price target of $30.00

    3/23/26 8:29:37 AM ET
    $WULF
    EDP Services
    Technology

    Arete initiated coverage on Hut 8 Mining with a new price target

    Arete initiated coverage of Hut 8 Mining with a rating of Buy and set a new price target of $136.00

    3/23/26 8:29:00 AM ET
    $HUT
    Finance: Consumer Services
    Finance

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Leadership Updates

    Live Leadership Updates

    View All

    PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio

    Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio.Octeris, Inc. subsidiary formed to advance endoscopic esophageal imaging technology recently licensed from Duke University.NEW YORK, April 2, 2026 /PRNewswire/ -- PAVmed Inc. (NASDAQ:PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it has appointed medical technology industry veteran Joseph Virgilio as Senior Vice President and Chief Business Officer, Medical Devices to oversee the development and commercialization of PAVmed's cur

    4/2/26 8:01:00 AM ET
    $LUCD
    $PAVM
    Medical/Dental Instruments
    Health Care

    Telix Appoints David Gill as Non-Executive Director

    MELBOURNE, Australia and INDIANAPOLIS, April 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ:TLX, "Telix") today announces the appointment of David Gill as a Non-Executive Director (NED), as part of Board expansion and succession planning. The appointment is effective May 11, 20261. Mr. Gill is expected to be appointed as Chair in due course, succeeding Dr. Mark Nelson who will remain on the Board as a NED. Mr. Gill is a life sciences executive with over 35 years' experience in senior general management and financial leadership roles across commercial and clinical-stage biopharmaceutical (including radiopharmaceuticals) and medical device companies. He current

    4/1/26 7:53:07 PM ET
    $EOLS
    $TLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum

    Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared Device Over 700 RenovoCath Procedures Successfully Completed Since FDA Clearance in 2014 Company Appoints Ramtin Agah, MD to the Additional Position of Executive Chairman to Support Continued Clinical Adoption and Commercial Growth MOUNTAIN VIEW, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or "the Company") (NASDAQ:RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced continued commercial progress, with

    2/27/26 8:30:00 AM ET
    $RNXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Financials

    Live finance-specific insights

    View All

    AVITA Medical to Announce First Quarter 2026 Financial Results

    VALENCIA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company, today announced that it will report its first quarter 2026 financial results after the close of the U.S. financial markets on Thursday, May 14, 2026. AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, May 15, 2026, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and recent business highlights. First Quarter 2026 Webcast and Conference Call InformationTo listen to the conference call webcast, please register and join using the following link: https://edge.media-serve

    4/23/26 4:10:00 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    Hut 8 Schedules First Quarter 2026 Earnings Release and Conference Call

    MIAMI, April 17, 2026 /PRNewswire/ -- Hut 8 Corp. ((Nasdaq, TSX:HUT) ("Hut 8" or the "Company"), an energy infrastructure platform integrating power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases, today announced it will release financial results for the first quarter of 2026 before the market opens on May 6, 2026. The Company will host a conference call and webcast to review the results on the same day at 8:30 a.m. ET. Conference Call and Webcast DetailsDate: Wednesday, May 6, 2026Time: 8:30 a.m. ETTo register for the webcast,

    4/17/26 6:30:00 AM ET
    $HUT
    Finance: Consumer Services
    Finance

    Riot Announces First Quarter 2026 Earnings Conference Call

    CASTLE ROCK, Colo., April 16, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ:RIOT) ("Riot" or "the Company"), a Bitcoin-driven industry leader in the development of large-scale data centers and bitcoin mining applications, announced today that it has scheduled its first quarter 2026 earnings conference call for Thursday, April 30, 2026, at 4:30 P.M. EST. This conference call will be available through an audio-only webcast. Please use this link here to register. Participants who choose to dial into the call in the United States or internationally, please use this link here to register. A replay of the webcast will be available after the call ends, through this link. About Riot Plat

    4/16/26 4:30:00 PM ET
    $RIOT
    Finance: Consumer Services
    Finance

    $ACHR
    $AGRI
    $ANY
    $ARVL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Citius Pharmaceuticals Inc.

    SC 13D/A - Citius Pharmaceuticals, Inc. (0001506251) (Subject)

    11/27/24 4:05:31 PM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Archer Aviation Inc.

    SC 13D/A - Archer Aviation Inc. (0001824502) (Subject)

    11/18/24 9:40:14 PM ET
    $ACHR
    Aerospace
    Industrials